Mast cells in the pathogenesis of chronic back pain: a hypothesis
Anthony J. Freemont
Musculoskeletal Research Group, Medical School, Manchester University, Manchester, UK
Search for more papers by this authorMaria Jeziorska
Musculoskeletal Research Group, Medical School, Manchester University, Manchester, UK
Search for more papers by this authorJudith A. Hoyland
Musculoskeletal Research Group, Medical School, Manchester University, Manchester, UK
Search for more papers by this authorPaul Rooney
Musculoskeletal Research Group, Medical School, Manchester University, Manchester, UK
Search for more papers by this authorCorresponding Author
Shant Kumar
Musculoskeletal Research Group, Medical School, Manchester University, Manchester, UK
Musculoskeletal Research Group, Medical School, Manchester University, Manchester M13 9PT, UK.Search for more papers by this authorAnthony J. Freemont
Musculoskeletal Research Group, Medical School, Manchester University, Manchester, UK
Search for more papers by this authorMaria Jeziorska
Musculoskeletal Research Group, Medical School, Manchester University, Manchester, UK
Search for more papers by this authorJudith A. Hoyland
Musculoskeletal Research Group, Medical School, Manchester University, Manchester, UK
Search for more papers by this authorPaul Rooney
Musculoskeletal Research Group, Medical School, Manchester University, Manchester, UK
Search for more papers by this authorCorresponding Author
Shant Kumar
Musculoskeletal Research Group, Medical School, Manchester University, Manchester, UK
Musculoskeletal Research Group, Medical School, Manchester University, Manchester M13 9PT, UK.Search for more papers by this authorAbstract
The pathophysiology of chronic low back pain is poorly understood, mainly because it is difficult to study experimentally or objectively. Recently it has been found that there is a relationship between neovascularization and innervation of the usually avascular and aneural intervertebral disc at the sites of discogenic pain. These data, together with the recognized involvement of mast cells in tissue repair, in the induction of angiogenesis, and in the production of and response to neurotrophic stimuli such as nerve growth factor, has suggested the hypothesis that mast cells may have a causative role in chronic low back pain. If so, the mast cell may represent an attractive therapeutic target. Copyright © 2002 John Wiley & Sons, Ltd.
References
- 1 Occupational Health Guidelines for the Management of Low back Pain at Work: Evidence Review and Recommendations. London: Faculty of Occupational Medicine of the Royal College of Physicians, 2000.
- 2Long DM. Chronic back pain. In Texbook of Pain ( 4th edn), PD Wall, R Melzack (eds). Churchill Livingstone: Edinburgh, 1999; 539–558.
- 3Freemont AJ, Peacock TE, Goupile P, Hoyland JA, O'Brien J, Jayson MIV. Nerve ingrowth into the diseased intervertebral disc in chronic back pain. Lancet 1997; 350: 178–181.
- 4Coppes MH, Marani E, Thomeer RT, Oudega M, Green GJ. Innervation of annulus fibrosus in low back pain. Lancet 1990; 336: 189–190.
- 5Grönblad M, Weinstein JN, Santavirta S. lmmunohistochemical observations on spinal tissue innervation: a review of hypothetical mechanisms of back pain. Acta Orthop Scand 1991; 62: 614–622.
- 6 Vernon-Roberts B. Age-related and degenerative pathology of intervertebral discs and apophyseal joints. In The Lumbar Spine and Back Pain ( 4th edn), MIV Jayson (ed.). Churchill Livingstone: Edinburgh, 1992; 24–37.
- 7Weinstein I, Claverie W, Gibson S. The pain of discography. Spine 1988; 13: 1344–1348.
- 8McCarthy PW, Carruthers B, Martin D, Petts P. Immunohistochemical demonstration of sensory nerve fibers and endings in lumbar intervertebral discs or the rat. Spine 1991; 16: 653–655.
- 9Bogduk N, Tynan W, Wilson AS. The nerve supply to the human lumbar intervertebral discs. J Anat 1981; 132: 39–56.
- 10Jackson HC, Winkelmann RK, Bickel WH. Nerve endings in the human lumbar spine column and related structures. J Bone Joint Surg Am 1966; 48: 1272–1281.
- 11Malinsky I. The ontogenetic development of nerve terminals in the intervertebral disc of man. Acta Anat 1959; 38: 96–113.
- 12Ahmed M, Bjurholm A, Kriebergs A, Schuftzberg A. Neuropeptide Y, tyrosine hydroxylase and vasoactive intestinal polypeptide-immunoreactive nerve fibres in the vertebral bodies, discs, dura mater and spinal ligaments of the rat lumbar spine. Spine 1993; 18: 268–273.
- 13McCarthy PW, Carruthers B, Martin D, Petts P. Immunohistochemical demonstration of sensory nerve fibres and endings in lumbar intervertebral discs of the rat. Spine 1991; 16: 653–655.
- 14Ashton IK, Roberts S, Jaffray DC, Polak JM, Eisenstein SM. Neuropeptides in the human intervertebral disc. J Orthop Res 1994; 12: 186–192.
- 15Konttinen YT, Grönblad M, Antti-Poika I, et al. Neuroimmunohistochemical analysis of peridiscal nociceptive neural elements. Spine 1990; 15: 383–386.
- 16Palmgren T, Grönblad M, Virri J, Seitsalo S, Ruuskanen M, Karaharju E. Immunohistochemical demonstration of sensory and autonomic severe terminals in herniated lumbar disc tissue. Spine 1996; 21: 1301–1306.
- 17Freemont AJ, Watkins A, Le Maitre C, Jeziorska M, Hoyland JA. Current understanding of cellular and molecular events in invertebral disc degeneration: implications for therapy. J Pathol 2002; 196: 374–379.
- 18Henry JL. Relation of substance P to pain transmission: neurophysiological evidence. Ciba Foundation Symp 1981; 91: 206–224.
- 19Woolf CI, Ma QP, Allchome A, Poole S. Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J Neurosci 1996; 16: 2716–2723.
- 20Rooney P, Kumar P, Ponting I, Kumar S. The role of collagens and proteoglycans in tumour angiogenesis. In Tumour Angiogenesis, R Bicknell, CE Lewis, N Ferrara (eds). Oxford University Press: Oxford, 1997; 141–151.
- 21Tetlow LC, Wooley DE. Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis 1995; 54: 896–903.
- 22Renoux M, Hiliquin P, Galoppin L, Florentin I, Menkes CJ. Release of mast cell mediators and nitrites into knee joint fluid in osteoarthritis: comparison with articular chondrocalcinosis and rheumatoid arthritis. Osteoarthritis Cartilage 1996; 4: 175–179.
- 23Galli SJ. Mast cells and basophils. Curr Opin Hematol 2000; 7: 32–39.
- 24Dines KC, Powell HC. Mast cell interactions with the nervous system: relationship to mechanisms of disease. J Neuropathol Expl Neurol 1997; 56: 627–640.
- 25Krüger PG, Bo L, Myhr KM, et al. Mast cells and multiple sclerosis: a light and electron microscopic study of mast cells in multiple sclerosis emphasizing staining procedures. Acta Neurol Scand 1990; 81: 31–36.
- 26GalIi SJ, Tsai M, Wershil BK. The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol 1993; 142: 965–974.
- 27Valent P. The riddle of the mast cell kit (CD117)-ligand as the missing link? Immunol Today 1994; 15: 111–114.
- 28Galli SJ, Zsebo KM, Geissler EN. The kit-ligand, stem cell factor. Adv Immunol 1994; 55: 1–96.
- 29Aloe L, Levi-Montalcini R. Mast cells increase in tissue of neonatal rats injected with nerve growth factor. Brain Res 1977; 133: 358–366.
- 30Aloe L, Probert L, Kollias G, Micera A, Tirassa P. Effect of NGF antibodies on mast cell distribution, histamine and substance P levels in the knee joint of TNF-arthritic transgenic mice. Rheumatol Int 1995; 14: 249–252.
- 31Hoyland JA, Freemont AJ, Jayson MIV. Age related changes inthe structures within and bordering the intervertebral foramen: associations with low back pain. In The Ageing Spine, DW Hukins, MA Nelson (eds). Manchester University Press: Manchester, 1987; 94–110.
- 32Norrby K. Heparin and angiogenesis: a low-molecular-weight fraction inhibits and a high-molecular-weight fraction stimulates angiogenesis systemically. Haemostasis 1993; Suppl. 1: 141–149.
- 33Blair RJ, Meng H, Marchese MJ, et al. Human mast cells stimulate vascular tube formation: tryptase is a novel, potent angiogenic factor. J Clin Invest 1997; 99: 2691–2700.
- 34Muramatsu M, Katada J, Hattori M, Hayashi I, Majima M. Chymase mediates mast-cell induced angiogenesis in hamster sponge granulomas. Eur J Pharmacol 2000; 402: 181–191.
- 35Anonymous. Exploiting angiogenesis. Lancet 1991; i: 208–209.
- 36Theoharides TC, Pang X, Letourneau R, Sant GR. Interstitial cystitis: a neuroimmunoendocrine disorder. Ann NY Acad Sci 1998; 840: 619–634.
- 37Grills BL, Schuijers JA. Immunohistochemical localization of nerve growth factor in fractured and unfractured rat bone. Acta Orthop Scand 1998; 69: 415–419.